Kolon TissueGene, Inc. is a biopharmaceutical company with various products pipelines.
MaxCyte
MaxCyte is a leading commercial cell-engineering company focused on providing enabling platform technologies to advance innovative cell-based research as well as next-generation cell therapeutic discovery, development and commercialization.
Immunomic Therapeutics
Immunomic Therapeutics, Inc. (ITI) is a privately-held clinical stage biotechnology company pioneering the study of the Universal Intracellular Targeted Expression (UNITE) nucleic acid immunotherapy platform.
Haffner Associates
Dedicated to facilitating the development of therapies for the diagnosis, treatment and prevention of rare and devastating diseases.
Exegi Pharma
ExeGi Pharma specializes in developing live biotherapeutic, human probiotic, and veterinary probiotic medicines.
Fina Biosolutions
Fina Biosolutions LLC is a research and development stage biotechnology company that discovers, develops, and collaborates to commercialize novel vaccine conjugates for prevention of life-threatening diseases. conjugates.
Chiesi Pharmaceuticals
Chiesi focused on research, development, production and commercialization of innovative therapeutic solutions in the Respiratory, Neonatology, Rare Diseases and Special Care Therapeutic Areas.
CASI Pharmaceuticals
CASI Pharmaceuticals focuses on developing and commercializing innovative therapeutics and pharmaceutical products in China, the United States, and throughout the world.